JUNSHI BIO(01877.HK)

Last Updated 08:00:00
longbridge loading

Hong Kong Biotech Stocks Decline Amid Market Volatility

CoinLive·
HK
09995
+2.41%
HK
01877
+1.68%
SH
688180
+1.33%
CoinLive·
HK
09995
+2.41%
HK
01877
+1.68%
SH
688180
+1.33%

Junshi Biosciences Board Approves 2026 Q1 Report at Fully Attended Meeting

Tip Ranks·
HK
01877
+1.68%
SH
688180
+1.33%
Tip Ranks·
HK
01877
+1.68%
SH
688180
+1.33%

Junshi Biosciences Shareholder Plans Up to 2% Stake Reduction

Tip Ranks·
SH
688180
+1.33%
HK
01877
+1.68%
SZ
159837
-0.22%
Tip Ranks·
SH
688180
+1.33%
HK
01877
+1.68%
SZ
159837
-0.22%

02:47 ET2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations

prnewswire·
SH
688180
+1.33%
HK
01877
+1.68%
US
FBT
+0.54%
prnewswire·
SH
688180
+1.33%
HK
01877
+1.68%
US
FBT
+0.54%

Shanghai Junshi Biosciences Sets Board Meeting to Approve Q1 2026 Results

Tip Ranks·
HK
01877
+1.68%
Tip Ranks·
HK
01877
+1.68%

Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase

Tip Ranks·
SH
512290
-0.32%
SZ
159615
-0.30%
SH
516930
-0.21%
Tip Ranks·
SH
512290
-0.32%
SZ
159615
-0.30%
SH
516930
-0.21%

Strong Growth in Innovative Drug Revenue, Biopharmaceutical Companies' Performance Shows High "Innovation" Content

Wallstreetcn·
SH
588250
+0.19%
SZ
159992
-0.13%
SH
688331
+4.03%
Wallstreetcn·
SH
588250
+0.19%
SZ
159992
-0.13%
SH
688331
+4.03%

The Hong Kong innovative drug sector continued to rise in the afternoon, with JOINN and CSPC PHARMA up over 10%, INNOVENT BIO up over 7%, and JUNSHI BIO and INNOCARE following suit

Wallstreetcn·
SH
513120
-0.36%
HK
01801
+0.56%
SH
603127
+1.72%
Wallstreetcn·
SH
513120
-0.36%
HK
01801
+0.56%
SH
603127
+1.72%

Shanghai Junshi Biosciences Schedules 2025 Results Briefing for Investor Q&A

Tip Ranks·
SH
688180
+1.33%
HK
01877
+1.68%
Tip Ranks·
SH
688180
+1.33%
HK
01877
+1.68%

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Wallstreetcn·
SH
688336
-1.41%
SH
688513
-1.54%
HK
01877
+1.68%
Wallstreetcn·
SH
688336
-1.41%
SH
688513
-1.54%
HK
01877
+1.68%
© 2026 Longbridge｜Disclaimer